Spots Global Cancer Trial Database for pxd101
Every month we try and update this database with for pxd101 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary | NCT00873119 | Carcinoma of Un... | belinostat, car... carboplatin, pa... | 18 Years - | Valerio Therapeutics | |
| Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma | NCT00865969 | Peripheral T-ce... | Belinostat | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma | NCT00131261 | Multiple Myelom... | PXD101 Dexamethasone | 18 Years - | Valerio Therapeutics | |
| Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy | NCT00878722 | Acute Myeloid L... | PXD101 idarubicin | 18 Years - | Valerio Therapeutics | |
| A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment | NCT00421889 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Bladder Cancer | belinostat Paclitaxel Carboplatin | 18 Years - | Valerio Therapeutics | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma | NCT00431340 | Multiple Myelom... | PXD101 | 18 Years - | Valerio Therapeutics | |
| Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary | NCT00873119 | Carcinoma of Un... | belinostat, car... carboplatin, pa... | 18 Years - | Valerio Therapeutics | |
| A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment | NCT00421889 | Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Bladder Cancer | belinostat Paclitaxel Carboplatin | 18 Years - | Valerio Therapeutics | |
| Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy | NCT00878722 | Acute Myeloid L... | PXD101 idarubicin | 18 Years - | Valerio Therapeutics | |
| A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma | NCT00431340 | Multiple Myelom... | PXD101 | 18 Years - | Valerio Therapeutics | |
| Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy | NCT00878722 | Acute Myeloid L... | PXD101 idarubicin | 18 Years - | Valerio Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
